Physician profile
Leticha Richards
NPI 1548833593
$644.52
in general payments reported to CMS, 2019-2025
12 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31.45 · 2023: $195 · 2024: $294 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $159.58 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $100.09 | 2023-2024 | Myosure Tissue Removal Device, Aptima, Novasure |
| Ethicon US, LLC | $73.28 | 2023 | Enseal |
| Mayne Pharma Commercial LLC | $68.27 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.13 | 2022-2023 | |
| Biogen, INC. | $54.80 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $36.86 | 2024 | Ova1 |
| Pacira Pharmaceuticals Incorporated | $24.62 | 2024 | Exparel |
| Millicent US INC | $21.30 | 2025 | Femlyv |
| Evofem Biosciences, INC. | $16.78 | 2023 | Phexxi |
| Avion Pharmaceuticals | $16.24 | 2023 | Balcoltra |
| Shield Therapeutics INC | $14.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leticha Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.